"My Company has been sold, now what?!?”

In this episode, Tom Caravela welcomes Steve St. Onge to discuss the intricacies of corporate acquisitions within the pharmaceutical industry. Steve shares his journey through corporate development and provides insight into the transition and management of acquisitions, both before and after announcements. The conversation delves into the emotional and strategic aspects of navigating acquisitions, identifying warning signs, and the impact of market volatility. Steve offers practical advice for decision-making during economic downturns and strategies for embracing change and new opportunities in the pharma sector. The episode concludes with a discussion on future innovation and optimism in biotech, along with closing remarks and gratitude to listeners.

Steve St. Onge, Sr Director Business Development and Corporate Communications at Paratek discusses what to expect after your company has been acquired.

Steve shares….

👉 What to expect when acquisition news hits
👉 How to handle emotions and not panic
👉 What steps you should take after acquisition news
👉 What are the warning signs to be aware of
👉 Why is the pharma / biotech sector so volatile these days

The podcast is available through the links below and anywhere podcasts can be found:

️ ️ 〰️ Spotify: https://lnkd.in/dRrSEyn

️ ️ 〰️ Apple: https://lnkd.in/egSthAz

️ ️ 〰️ Youtube: https://lnkd.in/dhaWVJU

MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversation and medical affairs discussions.

#msl #medicalaffairs #medicalscienceliaison #MSLTalk #pharmaceutical

(0:00) Introduction to guest Steve Saint An
(0:13) Announcements and Sponsor: Paratek Pharmaceuticals
(2:46) Overview of Steve Saint An's background and corporate development
(5:25) Transition and initial reactions to corporate acquisitions
(8:05) Behind-the-scenes pre-announcement activities
(12:09) Managing post-announcement events and emotions
(17:52) Practical advice for navigating acquisitions and warning signs
(24:54) Market volatility and factors affecting the pharmaceutical industry
(26:51) Decision-making during economic downturns
(29:56) Strategies for dealing with change post-acquisition
(31:08) Embracing new opportunities in the pharma industry
(33:04) Future of innovation and optimism in biotech
(34:49) Closing remarks and thanks to listeners